Medical Attributes of St. John's Wort (Hypericum perforatum)
Authors:
- Kenneth KlemowKKKenneth Klemow
- Andrew BartlowABAndrew Bartlow
- Justin CrawfordJCJustin Crawford
- Neil KocherNKNeil Kocher
- Jay ShahJSJay Shah
- Michael RitsickMRMichael Ritsick
- 28 March 2011
- book chapter
- Published by Taylor & Francis
- p. 211-237
Abstract
No abstract availableThis publication has 192 references indexed in Scilit:
- Effects of St. John's wort extract on indinavir pharmacokinetics in rats: Differentiation of intestinal and hepatic impactsLife Sciences, 2009
- Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fractionPhytochemistry, 2008
- The Effect of Hypericum perforatum (St. John’s Wort) on Experimental Colitis in RatDigestive Diseases and Sciences, 2008
- Does the Evidence Make a Difference in Consumer Behavior? Sales of Supplements Before and After Publication of Negative Research ResultsJournal of General Internal Medicine, 2008
- Efficacy of St. John’s wort extract WS® 5570 in acute treatment of mild depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2007
- Inhibition of Prostaglandin E2 Production by Anti-inflammatory Hypericum perforatum Extracts and Constituents in RAW264.7 Mouse Macrophage CellsJournal of Agricultural and Food Chemistry, 2007
- Influence of Hypericum perforatum extract and its single compounds on amyloid-β mediated toxicity in microglial cellsLife Sciences, 2007
- Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compoundsJournal of Photochemistry and Photobiology B: Biology, 2006
- Liquid chromatography–mass spectrometry studies of St. John's wort methanol extraction: active constituents and their transformationJournal of Pharmaceutical and Biomedical Analysis, 2005
- The interaction between St John's wort and an oral contraceptiveClinical Pharmacology & Therapeutics, 2003